158 related articles for article (PubMed ID: 35971121)
1. High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis.
Zhang G; Liu B; Shang H; Wu G; Wu D; Wang L; Li S; Wang Z; Wang S; Yuan J
BMC Med Genomics; 2022 Aug; 15(1):180. PubMed ID: 35971121
[TBL] [Abstract][Full Text] [Related]
2. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
[TBL] [Abstract][Full Text] [Related]
3. RNA binding protein serine/arginine splicing factor 1 promotes the proliferation, migration and invasion of hepatocellular carcinoma by interacting with RecQ protein-like 4 mRNA.
Ye Y; Yu F; Li Z; Xie Y; Yu X
Bioengineered; 2021 Dec; 12(1):6144-6154. PubMed ID: 34486474
[TBL] [Abstract][Full Text] [Related]
4. microRNA-802 inhibits cell proliferation and induces apoptosis in human cervical cancer by targeting serine/arginine-rich splicing factor 9.
Zhang Q; Lv R; Guo W; Li X
J Cell Biochem; 2019 Jun; 120(6):10370-10379. PubMed ID: 30565744
[TBL] [Abstract][Full Text] [Related]
5. The truncated AXIN1 isoform promotes hepatocellular carcinoma metastasis through SRSF9-mediated exon 9 skipping.
Zhang QQ; Miao YS; Hu JY; Liu RX; Hu YX; Wang F
Mol Cell Biochem; 2024 May; ():. PubMed ID: 38748384
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer.
Yoshino H; Enokida H; Chiyomaru T; Tatarano S; Hidaka H; Yamasaki T; Gotannda T; Tachiwada T; Nohata N; Yamane T; Seki N; Nakagawa M
Biochem Biophys Res Commun; 2012 Jan; 417(1):588-93. PubMed ID: 22178073
[TBL] [Abstract][Full Text] [Related]
7. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
8. Proline-rich protein 11 silencing inhibits hepatocellular carcinoma growth and epithelial-mesenchymal transition through β-catenin signaling.
Qiao W; Wang H; Zhang X; Luo K
Gene; 2019 Jan; 681():7-14. PubMed ID: 30248355
[TBL] [Abstract][Full Text] [Related]
9. MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.
Guan L; Li T; Ai N; Wang W; He B; Bai Y; Yu Z; Li M; Dong S; Zhu Q; Ding XX; Zhang S; Li M; Tang G; Xia X; Zhao J; Lin S; Yao S; Zhang L; Chen G; Liu FE; Li X; Zhang H
J Exp Clin Cancer Res; 2019 Oct; 38(1):417. PubMed ID: 31623651
[TBL] [Abstract][Full Text] [Related]
10. Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
Wang P; Guo L; Li K; Ning S; Shi W; Liu Z; Chen Y
Cancer Biomark; 2018 Feb; 21(3):681-687. PubMed ID: 29278882
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma.
Lin B; Zhou X; Lin S; Wang X; Zhang M; Cao B; Dong Y; Yang S; Wang JM; Guo M; Huang J
J Mol Med (Berl); 2017 Nov; 95(11):1237-1249. PubMed ID: 28844099
[TBL] [Abstract][Full Text] [Related]
12. Exploration of the effects of the CYCLOPS gene RBM17 in hepatocellular carcinoma.
Li C; Ge S; Zhou J; Peng J; Chen J; Dong S; Feng X; Su N; Zhang L; Zhong Y; Deng L; Tang X
PLoS One; 2020; 15(6):e0234062. PubMed ID: 32497093
[TBL] [Abstract][Full Text] [Related]
13. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA LINC02580 suppresses the invasion-metastasis cascade in hepatocellular carcinoma by targeting SRSF1.
Xu L; Wang Z; Yin C; Pan F; Shi T; Tian Y
Biochem Biophys Res Commun; 2020 Dec; 533(4):685-691. PubMed ID: 33168192
[TBL] [Abstract][Full Text] [Related]
15. Pan-Cancer Analysis Revealed
Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J
J Oncol; 2022; 2022():3477148. PubMed ID: 35069733
[TBL] [Abstract][Full Text] [Related]
16. AMP-activated protein kinase regulates β-catenin protein synthesis by phosphorylating serine/arginine-rich splicing factor 9.
Matsumoto E; Matsumoto Y; Inoue J; Yamamoto Y; Suzuki T
Biochem Biophys Res Commun; 2021 Jan; 534():347-352. PubMed ID: 33248688
[TBL] [Abstract][Full Text] [Related]
17. SF3B4 is regulated by microRNA-133b and promotes cell proliferation and metastasis in hepatocellular carcinoma.
Liu Z; Li W; Pang Y; Zhou Z; Liu S; Cheng K; Qin Q; Jia Y; Liu S
EBioMedicine; 2018 Dec; 38():57-68. PubMed ID: 30391496
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of GNA14 and its tumor-suppressive role in hepatitis B virus-related hepatocellular carcinoma.
Song G; Zhu X; Xuan Z; Zhao L; Dong H; Chen J; Li Z; Song W; Jin C; Zhou M; Xie H; Zheng S; Song P
Theranostics; 2021; 11(5):2318-2333. PubMed ID: 33500727
[TBL] [Abstract][Full Text] [Related]
19. Cyclin B2 Overexpression in Human Hepatocellular Carcinoma is Associated with Poor Prognosis.
Li R; Jiang X; Zhang Y; Wang S; Chen X; Yu X; Ma J; Huang X
Arch Med Res; 2019 Jan; 50(1):10-17. PubMed ID: 31101236
[TBL] [Abstract][Full Text] [Related]
20. Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
Cui XH; Peng QJ; Li RZ; Lyu XJ; Zhu CF; Qin XH
J Cell Mol Med; 2021 Dec; 25(24):11097-11112. PubMed ID: 34741389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]